In cases where DTH values are continuously increased with WT1-DC therapy, it is thought that the activation of anti-tumor immunity is occurring along with the improvement of IPS, increasing the possibility of prolonged overall survival even in late-stage cancer. This evidence concerns the gene WT1 and cancer.